BALVERSA^® is a prescription medicine used to treat adults with bladder cancer (urothelial cancer) that has spread or cannot be removed by surgery:

• which has a certain type of abnormal fibroblast growth factor receptor (FGFR) gene, and
• who have tried at least one other chemotherapy medicine that contains platinum, and it did not work or is no longer working.

Your healthcare provider will test your cancer for certain types of abnormal FGFR genes and make sure that BALVERSA^® is right for you.

It is not known if BALVERSA^® is safe and effective in children.

BALVERSA^® is approved based on tumor response. Data are not yet available to show if BALVERSA^® improves survival or symptoms.